Acarix Past Earnings Performance
Past criteria checks 0/6
Acarix's earnings have been declining at an average annual rate of -14.6%, while the Medical Equipment industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 36.2% per year.
Key information
-14.6%
Earnings growth rate
50.8%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 36.2% |
| Return on equity | -150.0% |
| Net Margin | -1,247.2% |
| Next Earnings Update | 14 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Acarix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 6 | -78 | 54 | 29 |
| 30 Sep 23 | 7 | -78 | 53 | 30 |
| 30 Jun 23 | 6 | -82 | 56 | 31 |
| 31 Mar 23 | 6 | -79 | 54 | 29 |
| 31 Dec 22 | 6 | -77 | 53 | 28 |
| 30 Sep 22 | 5 | -71 | 51 | 23 |
| 30 Jun 22 | 5 | -60 | 43 | 21 |
| 31 Mar 22 | 4 | -55 | 39 | 20 |
| 31 Dec 21 | 4 | -52 | 33 | 21 |
| 30 Sep 21 | 4 | -47 | 30 | 20 |
| 30 Jun 21 | 3 | -45 | 30 | 18 |
| 31 Mar 21 | 3 | -42 | 29 | 15 |
| 31 Dec 20 | 2 | -41 | 29 | 14 |
| 30 Sep 20 | 2 | -40 | 27 | 14 |
| 30 Jun 20 | 1 | -43 | 25 | 18 |
| 31 Mar 20 | 2 | -44 | 26 | 20 |
| 31 Dec 19 | 2 | -46 | 28 | 20 |
| 30 Sep 19 | 1 | -48 | 29 | 21 |
| 30 Jun 19 | 2 | -50 | 33 | 19 |
| 31 Mar 19 | 1 | -47 | 32 | 16 |
| 31 Dec 18 | 1 | -42 | 31 | 12 |
| 30 Sep 18 | 1 | -43 | 32 | 11 |
| 30 Jun 18 | 1 | -37 | 30 | 8 |
| 31 Mar 18 | 1 | -34 | 28 | 7 |
| 31 Dec 17 | 1 | -30 | 26 | 5 |
| 30 Sep 17 | 0 | -32 | 30 | 4 |
| 30 Jun 17 | 0 | -55 | 31 | 2 |
| 31 Mar 17 | 0 | -50 | 28 | 1 |
| 31 Dec 16 | 0 | -48 | 26 | 1 |
| 30 Sep 16 | 0 | -35 | 11 | 3 |
| 31 Dec 15 | 0 | -12 | 7 | 9 |
Quality Earnings: ACARIX is currently unprofitable.
Growing Profit Margin: ACARIX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ACARIX is unprofitable, and losses have increased over the past 5 years at a rate of 14.6% per year.
Accelerating Growth: Unable to compare ACARIX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ACARIX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (59.4%).
Return on Equity
High ROE: ACARIX has a negative Return on Equity (-150.02%), as it is currently unprofitable.